JPWO2021195508A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021195508A5
JPWO2021195508A5 JP2022558189A JP2022558189A JPWO2021195508A5 JP WO2021195508 A5 JPWO2021195508 A5 JP WO2021195508A5 JP 2022558189 A JP2022558189 A JP 2022558189A JP 2022558189 A JP2022558189 A JP 2022558189A JP WO2021195508 A5 JPWO2021195508 A5 JP WO2021195508A5
Authority
JP
Japan
Prior art keywords
regitope
blood component
cells
regulatory
modified polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022558189A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023520989A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/024377 external-priority patent/WO2021195508A1/en
Publication of JP2023520989A publication Critical patent/JP2023520989A/ja
Publication of JPWO2021195508A5 publication Critical patent/JPWO2021195508A5/ja
Pending legal-status Critical Current

Links

JP2022558189A 2020-03-27 2021-03-26 １型糖尿病の予防および治療に有用なｔレジトープ構築物 Pending JP2023520989A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063000590P 2020-03-27 2020-03-27
US63/000,590 2020-03-27
PCT/US2021/024377 WO2021195508A1 (en) 2020-03-27 2021-03-26 Tregitope constructs useful in the prevention and treatment of type 1 diabetes

Publications (2)

Publication Number Publication Date
JP2023520989A JP2023520989A (ja) 2023-05-23
JPWO2021195508A5 true JPWO2021195508A5 (enExample) 2024-02-14

Family

ID=77890539

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022558189A Pending JP2023520989A (ja) 2020-03-27 2021-03-26 １型糖尿病の予防および治療に有用なｔレジトープ構築物

Country Status (4)

Country Link
US (1) US20230158165A1 (enExample)
EP (1) EP4126907A1 (enExample)
JP (1) JP2023520989A (enExample)
WO (1) WO2021195508A1 (enExample)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1191273C (zh) * 1999-05-17 2005-03-02 康久化学公司 长效促胰岛肽
WO2015085318A2 (en) * 2013-12-06 2015-06-11 Moderna Therapeutics, Inc. Targeted adaptive vaccines
CA3077084A1 (en) * 2017-10-05 2019-04-11 Epivax, Inc. Regulatory t cell epitopes

Similar Documents

Publication Publication Date Title
JP2023515386A (ja) 制御性ｔ細胞エピトープと脱寛容化ｓａｒｓ－ｃｏｖ－２抗原
JP2021107444A (ja) 調節性ｔ細胞エピトープ、組成物およびその使用
JP2023106434A (ja) 制御性ｔ細胞エピトープ
US11911414B2 (en) Regulatory T cell epitopes
JP2023520989A (ja) １型糖尿病の予防および治療に有用なｔレジトープ構築物
US20230279072A1 (en) Regulatory t cell epitopes
US20240173377A1 (en) Retro - inverso regulatory t cell epitopes
JP2023538002A (ja) 制御性ｔ細胞エピトープ
JPWO2021195508A5 (enExample)
JPWO2022036193A5 (enExample)
JPWO2021195492A5 (enExample)
HK1242342A1 (en) Regulatory t cell epitopes, compositions and uses thereof
HK1197250B (en) Regulatory t cell epitopes, compositions and uses thereof